Drug Profile
Research programme: hormone therapies - Viramal
Latest Information Update: 04 Sep 2023
Price :
$50
*
At a glance
- Originator Viramal
- Class Hormonal contraceptives; Hormones
- Mechanism of Action Estrogen receptor agonists; Estrogen receptor antagonists; Progesterone receptor agonists; Progesterone receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Endometriosis; Menopausal syndrome; Pregnancy
Most Recent Events
- 04 Sep 2023 Discontinued - Preclinical for Endometriosis in United Kingdom (Vaginal), prior to September 2023 (Viramal pipeline, September 2023)
- 04 Sep 2023 Discontinued - Preclinical for Menopausal syndrome in United Kingdom (Topical), prior to September 2023 (Viramal pipeline, September 2023)
- 04 Sep 2023 Discontinued - Preclinical for Menopausal syndrome in United Kingdom (Transdermal), prior to September 2023 (Viramal pipeline, September 2023)